
SINT Stock Forecast & Price Target
SINT Analyst Ratings
Bulls say
SINTX Technologies Inc. is positioned for a favorable financial outlook due to a strong net present value (NPV) analysis indicating substantial upside potential in its stock price. The company's focus on the biomedical sector, coupled with recent commercialization efforts and strategic acquisitions, is expected to enhance its market position and revenue generation capabilities. Additionally, the anticipated growth of the global antimicrobial fertilizer and crop protection market, projected to reach $10 billion by 2030, aligns with SINTX's offerings and presents further opportunities for expansion.
Bears say
SINTX Technologies reported a net loss of $2.3 million, translating to an earnings per share (EPS) of $(0.91), which fell short of prior estimates of $(0.79). The company faces multiple risks, including challenges related to liquidity, regulatory approvals, and the successful commercialization of its products, all of which could hinder its financial performance. Additionally, broader factors such as competition and changes in healthcare priorities present significant obstacles that may adversely affect investor sentiment and market confidence in the stock.
This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
SINT Analyst Forecast & Price Prediction
Start investing in SINT
Order type
Buy in
Order amount
Est. shares
0 shares